Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa

Open Access

Viewpoints are opinion pieces grounded in evidence on topics of broad interest to the journal's readership.

Peter U. Fischer ,

* E-mail: Pufische@DOM.wustl.edu

Affiliation Infectious Diseases Division, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America
⨯
Christopher L. King,

Affiliation Case Western Reserve University, Cleveland, Ohio, United States of America
⨯
Julie A. Jacobson,

Affiliation Bill and Melinda Gates Foundation, Seattle, Washington, United States of America
⨯
Gary J. Weil

Affiliation Infectious Diseases Division, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America
⨯

Reader Comments (0)

Onchocerciasis
Is the Subject Area "Onchocerciasis" applicable to this article?

Thanks for your feedback.
Africa
Is the Subject Area "Africa" applicable to this article?

Thanks for your feedback.
Adverse events
Is the Subject Area "Adverse events" applicable to this article?

Thanks for your feedback.
Onchocerca volvulus
Is the Subject Area "Onchocerca volvulus" applicable to this article?

Thanks for your feedback.
Ophthalmology
Is the Subject Area "Ophthalmology" applicable to this article?

Thanks for your feedback.
Eyes
Is the Subject Area "Eyes" applicable to this article?

Thanks for your feedback.
Randomized controlled trials
Is the Subject Area "Randomized controlled trials" applicable to this article?

Thanks for your feedback.
Loa loa
Is the Subject Area "Loa loa" applicable to this article?

Thanks for your feedback.